Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Influenza
Older adults
2023
2021
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(181)
Topics
Available to download in languages
Regions
Africa
(2)
Americas
(1)
Eastern Mediterranean
(1)
Europe
(4)
South-East Asia
(1)
Western Pacific
(3)
Countries
Diseases
COVID-19
(163)
Human papillomavirus (HPV)
(5)
Influenza
(15)
Diphtheria
(1)
Ebola
(1)
Hepatitis B
(3)
Herpes zoster
(10)
Pertussis
(1)
Pneumococcal disease
(9)
RSV (Respiratory syncytial virus)
(4)
Tetanus
(2)
Tick-borne encephalitis
(1)
Vaccine topics
Acceptance
(15)
Administration
(16)
Coverage
(5)
Economic aspects
(2)
Efficacy/effectiveness
(62)
Ethical issues
(6)
Safety
(72)
Target population
Older adults
(182)
Adolescents
(90)
Adults
(234)
All age groups
(215)
Children
(26)
Healthcare workers
(54)
Newborn
(10)
Parents/caregivers
(27)
Pregnant women
(46)
Risk group
(2)
Publication date
2023
(65)
2021
(117)
2024
(1)
2022
(208)
2020
(65)
2019
(10)
2018
(12)
2017
(8)
2016
(7)
2015
(4)
2014
(6)
2013
(4)
2012
(3)
2011
(2)
182 results found
2021
∙
Hariyanto, T. I. Rosalind, J. Christian, K. Kurniawan, A.
Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
2021
∙
Becerril-Gaitan, Andrea Vaca-Cartagena, Bryan F. Ferrigno, Ana S. Mesa-Chavez, Fernanda Barrientos-Gutiérrez, Tonatiuh Tagliamento, Marco Lambertini, Matteo Villarreal-Garza, Cynthia
Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis
2021
∙
Kalaij, A. G. I. Dirjayanto, V. J. Yusuf, S. M. Nelwan, E. J.
Immunogenicity and safety of adenovirus-based vector vaccines for COVID-19: a systematic review and meta-analysis
2021
∙
Lau, Oscar Vadlamudi, Nirma Khatri
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
2021
∙
Zhang, K. Wu, X. Shi, Y. Gou, X. Huang, J.
Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis
2021
∙
Akyol, M. Çevik, E. Ucku, D. Tanrıöver, C. Afşar, B. Kanbay, A. Covic, A. Ortiz, A. Basile, C. Kanbay, M.
Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review
2021
∙
Nguyen, J. Hardigan, P. Kesselman, M. M. Demory Beckler, M.
Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
2021
∙
Chen, J. J. Lee, T. H. Tian, Y. C. Lee, C. C. Fan, P. C. Chang, C. H.
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis
2021
∙
Maddaloni, E. D'Onofrio, L. Siena, A. Luordi, C. Mignogna, C. Amendolara, R. Cavallari, I. Grigioni, F. Buzzetti, R.
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
2021
∙
Mishra, P. Parveen, R. Bajpai, R. Samim, M. Agarwal, N. B.
Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register